PLEASANTON, Calif., Aug. 28, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation. As a global leader in biotechnology, Amgen ...

Amgen has entered a partnership to use Veeva Systems’ comprehensive Clinical Platform to enhance trial processes. This collaboration also aims to advance innovation in clinical trials and expedite the ...

Amgen will employ the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process. "We're excited to help Amgen further advance clinical development. Veeva Clinical ...

Veeva Systems, a company that provides cloud-based software, data, and consulting services specifically tailored for the life sciences industry, announced a collaboration with Amgen to advance ...

I believe Veeva's robust product roadmap, including the introduction of Veeva AI, should deepen adoption and drive productivity across its Development and Commercial Cloud segments. Despite a ...

"Prominent players in the Electronic Clinical Outcome Assessment (eCOA) Solutions market include include Signant Health (US), IQVIA HOLDINGS INC, (US), Oracle Corporation (US), Kayentis (France), ...

Veeva Systems, a global leader in cloud software for the life sciences industry, and Sarah Cannon Research Institute (SCRI), one of the world's leading oncology research organizations conducting ...

Q4 2026 Earnings Call March 4, 2026 5:00 PM ESTCompany ParticipantsGunnar Hansen - Director of Investor RelationsPeter Gassner ...